Chimeric Antigen Receptor T-Cell Therapy: A Beacon of Hope in the Fight Against Cancer

Despite significant advancements, relapses, and persistent malignancies are still a major challenge faced by the oncologists. Immunotherapy has shown remarkable potential in induction of sustained remission in refractory malignancies. Chimeric antigen receptor T-cell (CAR-T) therapy is a newer treat...

Descripción completa

Detalles Bibliográficos
Autores principales: Tariq, Syed Maaz, Haider, Syed Ali, Hasan, Mohammad, Tahir, Amber, Khan, Maria, Rehan, Arisha, Kamal, Anum
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cureus 2018
Materias:
Internal Medicine
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6314790/
https://www.ncbi.nlm.nih.gov/pubmed/30613448
http://dx.doi.org/10.7759/cureus.3486

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6314790/
https://www.ncbi.nlm.nih.gov/pubmed/30613448
http://dx.doi.org/10.7759/cureus.3486

Ejemplares similares